GenMark Diagnostics, Inc
GNMK
GNMK was delisted on the 21st of April, 2021.
89 hedge funds and large institutions have $392M invested in GenMark Diagnostics, Inc in 2015 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 39 increasing their positions, 21 reducing their positions, and 5 closing their positions.
180% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 5
86% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 21
39% more call options, than puts
Call options by funds: $64K | Put options by funds: $46K
11% more funds holding
Funds holding: 80 → 89 (+9)
29% less capital invested
Capital invested by funds: $550M → $392M (-$158M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GTC
Ghost Tree Capital
New York
|
+$7.56M |
| 2 |
CCM
Cadian Capital Management
New York
|
+$4.88M |
| 3 |
FAM
Fred Alger Management
New York
|
+$3.74M |
| 4 |
JGC
J. Goldman & Co
New York
|
+$3.03M |
| 5 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
+$2.17M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
-$6.75M |
| 2 |
Parnassus Investments
San Francisco,
California
|
-$6.1M |
| 3 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$4.69M |
| 4 |
Millennium Management
New York
|
-$2M |
| 5 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$1.88M |
GNMK Hedge Fund Activity: Q2 2015 in Review
89 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in GenMark Diagnostics, Inc (GNMK) for Q2 2015, worth a combined $392M — down 29% from $550M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new GNMK positions and 5 closed out — a net gain of 9 holders — while 39 added to existing stakes and 21 trimmed.
The largest buyer was Ghost Tree Capital, opening a new position worth an estimated $7.56M. The largest seller was Jennison Associates, cutting an estimated $6.75M.
- 89 institutional investors held GenMark Diagnostics, Inc (GNMK) as of Q2 2015, up from 80 in Q1 2015.
- Funds reported $392M of GenMark Diagnostics, Inc stock for Q2 2015, down 29% quarter-over-quarter.
- 14 funds opened new GenMark Diagnostics, Inc positions in Q2 2015 and 5 closed out, a net change of +9 holders.
- The largest GenMark Diagnostics, Inc buyer in Q2 2015 was Ghost Tree Capital, an estimated $7.56M added.
- The largest GenMark Diagnostics, Inc seller in Q2 2015 was Jennison Associates, an estimated $6.75M sold.
Based on aggregated 13F filings for Q2 2015.